Understanding how obesity affects asthma treatment in children
Systemic Corticosteroid Pharmacokinetics and Pharmacodynamic Biomarker Identification in Children with Asthma and Obesity
This study is looking at how being overweight might change how well asthma medications work for kids, so we can find better ways to treat asthma in children who are obese.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Mercy Hosp (Kansas City, Mo) NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11054439 on NIH RePORTER |
What this research studies
This research investigates how obesity influences the effectiveness and safety of systemic corticosteroids used to treat asthma in children. By focusing on pharmacokinetics (how the body processes medication) and pharmacodynamics (how the medication affects the body), the study aims to identify biomarkers that can help tailor asthma treatments for children with obesity. The research will involve analyzing the unique asthma characteristics in these children, which may lead to more personalized and effective treatment strategies. Dr. Kathryn Kyler, the principal investigator, will utilize her expertise to enhance understanding of these relationships over a five-year period.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been diagnosed with asthma and are also experiencing obesity.
Not a fit: Patients without asthma or those who do not have obesity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective asthma treatments specifically designed for children with obesity, improving their health outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the pharmacokinetics and pharmacodynamics of medications in pediatric populations, indicating that this approach could yield valuable insights.
Where this research is happening
Kansas City, United States
- Children's Mercy Hosp (Kansas City, Mo) — Kansas City, United States (Active)
Researchers
- Principal investigator: Kyler, Kathryn Ellen Dotts — Children's Mercy Hosp (Kansas City, Mo)
- Study coordinator: Kyler, Kathryn Ellen Dotts
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.